-Veeva MedTech Clinical Trials Report presents a great opportunity to improve the delivery and quality of data

83% use email, portals and paper to exchange information with study partners, slowing study execution and increasing risk of non-compliance.

BARCELONA, Spain, April 19, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today released its first report examining global trends in medical technology clinical trials. According to the 2023 Veeva MedTech Clinical Benchmark Report, timely data entry and data quality are the top challenges for medtech when working with clinical research sites. This can delay trials and increase the risk of compliance, so improving collaboration with study centers is a critical priority for faster delivery of high-quality data.

Research reveals that the majority of medtech companies (83%) rely on manual methods of sharing information with study stakeholders, such as email, portals, and paper. Manual methods of information exchange slow down study execution and data analysis, increasing the time and costs required to complete trial activities. With regulations like the EU MDR and IVDR requiring more clinical trials and performance data, there is a near-term opportunity to advance medical technology studies to be faster and more efficient.

The report highlights major areas for improvement and progress in medical technology clinical research, including:

"The medtech industry has a significant opportunity to modernize clinical systems and processes for faster access to trial data," said Kevin Liang, Vice President of Vault Clinical Strategy, Veeva MedTech. "As more organizations prioritize digital clinical technologies, medtech can improve collaboration with stakeholders and drive trial efficiency, productivity and compliance."

The Veeva MedTech Clinical Benchmark study examined how organizations—ranging from start-ups to large device and diagnostics companies—manage clinical processes, cross-study collaboration, and trial data to ensure compliance and speed. This report includes the views of more than 135 clinical medical technology professionals from around the world, highlighting the current challenges and near-term priorities associated with conducting clinical trials. Check out the full report, which investigates how medtech companies manage clinical operations, outsourcing, clinical post-market follow-up, and modernization.

About Veeva Systems Veeva is the world leader in cloud software for the life sciences industry. Committed to innovation, product excellence and customer success, Veeva serves more than 1,000 customers, from the world's largest pharmaceutical companies to emerging biotech companies. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com/eu.

Photo - https://mma.prnewswire.com/media/2057661/Veeva_Systems_Clinical_Benchmark_Report_PR_chart_Infographic.jpgLogo - https://mma.prnewswire.com/media/1488285/Veeva_Systems_Logo.jpg

View original content: https://www.prnewswire.com/news-releases/el-informe-de-veeva-supone-una-gran-oportunidad-para-mejorar-la-entrega-y-la-calidad-de-los-datos-301801769.html